Analgesics in Greece is set to record a robust performance in 2026, with retail sales expected to reach EUR207 million and a year-on-year value increase of 3%. Growth is being propelled not by demographic changes, as the population marginally decreases, but by a decisive shift in consumer preference towards premium, dual-action products and innovative, convenience-led delivery formats. The environment is particularly attractive due to a combination of sustained consumer spending, regulatory measures that accelerate the introduction of higher-value over-the-counter options, and the dominance of established brands that leverage pharmacist trust and targeted marketing. Success depends on the ability to innovate in product formulation and format, cultivate brand credibility among both healthcare professionals and consumers, and fully capitalise on the exclusive pharmacy channel that underpins distribution and engagement.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Greece with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Greece, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Greece report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Greece?
- Which are the leading brands in Analgesics in Greece?
- How are products distributed in Analgesics in Greece?
- How has the regulatory and operating environment for Analgesics changed in Greece?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Haleon accelerates premium pain relief with dual-action launch
Vian attracts on-the-go users with single-dose paracetamol formats
Regulatory changes fuel consumer trade-up to premium pain relief
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Combination product brands must focus on instilling trust to secure growth
Further innovation in convenience-led formats expected to address busy lifestyles
Regulatory reform set to expand OTC options and boost premium brand resilience
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Vian and Haleon strengthen leadership through innovation and trust
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies maintains dominant access as analgesics remain offline
Chart 1 Retail Channels 2021-2026
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!